Bucindolol exerts agonistic activity on the propranolol-insensitive state of β1-adrenoceptors in human myocardium

Journal of Pharmacology and Experimental Therapeutics

Volumn 300, Issue 3, 2002, Pages 794-801

  Bundkirchen, Andreas ^a   Brixius, Klara ^a   Olck, Birgit B ^a   Schwinger, Robert H G ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; BETA 1 ADRENERGIC RECEPTOR; BUCINDOLOL; FORSKOLIN; METOPROLOL; N(G) NITROARGININE; NEBIVOLOL; PROPANOL;

ADULT; AGONIST; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; FEMALE; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN TISSUE; INOTROPISM; INTRINSIC SYMPATHOMIMETIC ACTIVITY; MALE; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; AGED; ATRIAL FUNCTION, RIGHT; BENZOPYRANS; ETHANOLAMINES; FEMALE; HEART; HUMANS; MALE; METOPROLOL; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; PAPILLARY MUSCLES; PROPANOLAMINES; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA-1; VENTRICULAR FUNCTION, LEFT;

EID: 0036182190     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.300.3.794     Document Type: Article

References (41)

1. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure
2. Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity
3. Positive inotropic effects due to partial agonistic activity of the beta-adrenoceptor antagonist celiprolol following amplification of cAMP formation in failing human myocardium
4. Decreased catecholamine sensitivity and β-adrenergic-receptor density in the failing human hearts
5. Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in human myocardium
6. 2+-transients in the human heart
7. 2-adrenoceptors in the human heart: Properties, function, and alterations in chronic heart failure
8. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II)
9. Phosphodiesterase III inhibitors: Long-term risks and short-term benefits
10. 1-receptor transgenic mice
11. 2+ transients in mouse ventricular myocytes
12. Effect of race in the response to metoprolol in patients with congestive heart failure secondary to ideopathic dilated or ischemic cardiomyopathy
13. 3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle
14. Nitric oxide synthase inhibitors: Amino acids
15. Mechanisms of action of bucindolol in human ventricular myocardium
16. Molecular mechanism of β-adrenergic receptor blockers with intrinsic sympathomimetic activity
17. 4-adrenoceptor pharmacology
18. Modulation of human cardiac function through 4 β-adrenoceptor populations
19. 3-adrenoceptor knockout mice
20. 4-adrenoceptor mediated responses occur in parallel in a rat model of cardiac failure
21. 3-adrenergic-independent effects of CGP 12177 in brown adipose tissue
22. Different intrinsic activities of bucindolol, carvedilolol and metoprolol in human failing myocardium
23. Characterization of beta(1)-selectivity, adrenoceptor-G(s)-protein interaction and inverse agonism of nebivolol in human myocardium
24. 3-adrenoceptors
25. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)
26. 3H]CGP 12.177, generally classified as an antagonist, is a thermogenic agonist in brown adipose tissue
27. Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium
28. Effect of carvedilol on survival in severe chronic heart failure
29. The human cardiac atypical β-adrenoceptor stimulates a cyclic AMP-dependent pathway
30. 3H]CGP 12.177 binding
31. The effect of xamoterol in failing human myocardium
32. Different β-adrenoceptoreffector coupling in human ventricular and atrial myocardium
33. CGP 12.177: A hydrophilic β-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells
34. Bucindolol has no intrinsic sympathomimetic activity (ISA) in nonfailing human ventricular preparations
35. Vasodilating properties of beta-adrenoceptor blockers with intrinsic sympathomimetic activity
36. Affinity and selectivity of β-adrenoceptor antagonists in vitro
37. In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats
38. Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties
39. Xamoterol in severe heart failure
40. 2-adrenergic signal transduction
41. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure